Both in Pharmaceuticals
Bausch Health Companies vs Mineralys Therapeutics
Over the past year BHC returned −10.4% and MLYS returned −37.8%; their daily moves had a correlation of 0.12.
BHC −10.4% MLYS −37.8%Growth of $1, one year, split-adjusted
| Metric | BHC | MLYS |
|---|---|---|
| Price | $5.80 | $24.48 |
| Market cap | $2.17B | $2.16B |
| Today | +0.52% | −4.49% |
| 1 month | −8.2% | −4.4% |
| 6 months | +15.3% | +4.1% |
| Year to date | −16.5% | −32.5% |
| 1 year | −10.5% | −38.8% |
| Revenue growth (YoY) | +12.7% | — |
| Gross margin | 72.9% | — |
| Net margin | 9.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | -$18.94B | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | 72.8% | 51.4% |
| Short % of float | 3.8% | 15.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).